#United States #Stamford #Research to Practice #Lockwood Group #Oncology Education

The Lockwood Group Expands Capabilities by Welcoming Research To Practice

On November 12, 2025, The Lockwood Group, a leader in global health care services, announced its strategic acquisition of Research To Practice (RTP). This marks a significant development aimed at augmenting the company’s educational offerings in oncology.

Elevating Healthcare Standards

The Lockwood Group specializes in translating complex scientific data into actionable strategies, partnering with pharmaceutical and biotechnology firms to drive clinical success. By bringing RTP into its fold, the organization intends to enhance its suite of services, particularly in medical education focused on oncology.

Founder and CEO Matthew Schecter expressed his enthusiasm about this acquisition, stating, “We are thrilled to welcome Research To Practice to The Lockwood Group. RTP's deep expertise in oncology, their trusted relationships with clinical thought leaders, and their legacy of delivering best-in-class continuing education align seamlessly with The Lockwood Group's science-first, insight-driven approach.”

A Legacy of Oncology Education

Founded by prominent medical oncologist Neil Love, MD, RTP has over 40 years of experience in providing accredited educational programs designed for healthcare professionals working in oncology. Their unique courses include live events, local meetings, and multimedia webinars which not only keep clinicians informed but also engage them in real-world clinical challenges, enhancing their professional development and capabilities. Dr. Love noted, “Joining The Lockwood Group provides us the opportunity to further advance our mission of improving cancer care through education.”

A Unified Mission

The Lockwood Group and Research To Practice share a common goal: to empower clinicians and improve patient care through education. This partnership is set to unify their efforts in broadening access to trusted, evidence-based information, ultimately leading to improved medical decisions and patient outcomes within the oncology community.

The Path Forward

This acquisition represents a pivotal moment for The Lockwood Group, demonstrating its commitment to expanding its capabilities and improving patient care. With over 700 employees dedicated to advancing medical communications, regulatory consultations, and market access, The Lockwood Group is well-positioned to integrate RTP’s educational platform into its overarching strategy.

As the oncology landscape continues to evolve, the partnership with RTP is a proactive measure to equip healthcare providers with the necessary tools and information. Their ongoing collaboration aims to elevate standards in cancer care, ensuring clinicians are well-prepared to address the challenges they face in treating patients. Through innovative educational approaches and rich resources that both organizations bring, the partnership promises to significantly impact the quality of care provided to cancer patients across the globe.

For those interested in learning more about The Lockwood Group and their services, more details can be found on their official website, The Lockwood Group. Similarly, insights into Research To Practice and their educational initiatives can be explored at Research To Practice.